LIU Yan, XU Chao-qian, JIAO Jun-dong, WANG Hui-zhen, DONG De-li, YANG Bao-feng. M3-R/IKM3a new target of antiarrhythmic agentsJ. Acta Pharmaceutica Sinica, 2005, 40(1): 8-8.
Citation: LIU Yan, XU Chao-qian, JIAO Jun-dong, WANG Hui-zhen, DONG De-li, YANG Bao-feng. M3-R/IKM3a new target of antiarrhythmic agentsJ. Acta Pharmaceutica Sinica, 2005, 40(1): 8-8.

M3-R/IKM3a new target of antiarrhythmic agents

  • AimTo investigate the relationship between M3-R/IKM3 and arrhythmia in order to find a new target for antiarrhythmic agents. MethodsUsing the acute ischemic model of rats and patch-clamp techniques, the effects of the M3 receptor on the occurrence of arrhythmias and its possible mechanisms were studied. ResultsIn acute ischemic model of rats, the M3 receptor antagonist 4-diphenylacetoxy-n-methylpiperidine-methiodide (4DAMP) increased the occurrence of arrhythmias, and the M3 receptor agonist choline suppressed the onset and the development of arrhythmias (P<0.01). No change was observed after treatment with other receptor antagonists (M1, M2, and M4). With patch-clamp techniques, it was found that choline induced K+ current could be inhibited by 4DAMP. Antagonists toward M1, M2,and M4 receptors all failed to alter the current. ConclusionCholine modulates the cellular electrical properties of the heart, probably by activating a K+ current via stimulation of the M3 receptor. M3-R/IKM3 may act as a new target for antiarrhythmic agents.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return